Raxone® treatment for patients with dominant optic atrophy due to OPA1 gene mutation- a pilot study
- Katharina Valentin-Singer (Speaker)
- T Georgi (Author)
- Aminfar, H. (Author)
- Christoph Singer (Author)
- Wedrich, A. (Author)
- Mona Regina Schneider (Author)
Activity: Talk, presentation or poster › Scientific talk or presentation › Online